// App-Quantinova.ai

11499 : Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction

Researchers

Presenter

  • Seigo Sugiyama

Principal Investigators

  • Eiichi Akiyama

  • Hirofumi Kurokawa

  • Hirofumi Maeda

  • Koichiro Fujisue

  • Koichi Sugamura

  • Eiichiro Yamamoto

  • Hisao Ogawa

Medical Centers

  • Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Angina

  • Ischemic stroke

  • Congestive heart failure

  • Diabetes

  • Stroke

Biomarkers

  • B-type natriuretic peptide

  • Pentraxin-3

  • High sensitivity C-reactive protein

Drug/Treatment

  • ILS-969

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved